Niquitin Minitab Citrusízű (Nicotine)

Nicotine, the active ingredient in Niquitin Minitab Citrusízű, is a nicotine drug class presented as an unspecified strength/oromucosal form for oromucosal use. It is intended to aid smoking cessation in adult tobacco users. By reducing cravings and withdrawal symptoms, it supports the quitting process.

GNH USA supplies Niquitin Minitab Citrusízű as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for cross‑border procurement. Customers benefit from reliable lead times and dedicated technical support throughout the supply chain.

Nicotine is used in smoking cessation therapy to address nicotine dependence and related withdrawal. - Smoking cessation: helps adult smokers quit by delivering controlled nicotine to reduce cravings. - Tobacco dependence: supports reduction of daily tobacco intake during a quit attempt. - Nicotine withdrawal: alleviates symptoms such as irritability, anxiety, and difficulty concentrating.

Nicotine replacement products can cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: soreness or tingling of the oral mucosa. - Nausea: feeling of stomach upset after use. - Throat irritation: scratchy sensation in the throat. - Dizziness: light‑headed feeling, especially when standing quickly.

Serious or Rare Side Effects: - Hypertension: elevated blood pressure requiring medical attention. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Seizures: rare neurologic event associated with high nicotine exposure.

When using nicotine oral mucosal products, several safety considerations apply. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: consider potential nicotine exposure to the infant; seek medical advice. - Cardiovascular disease: monitor blood pressure and heart rate during therapy. - Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously. - Children and adolescents: not recommended for individuals under 18 years of age. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicotine may interact with other medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause excessive hypertensive response. - Insulin or oral hypoglycemics: nicotine can affect glucose control, requiring dose adjustment. - Theophylline: nicotine may increase plasma theophylline concentrations.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): can reduce nicotine metabolism, increasing exposure. - Antidepressants (SSRIs, SNRIs): may enhance nicotine‑related side effects such as nausea. - Antihypertensive agents: nicotine may diminish their efficacy, necessitating blood pressure monitoring.